Deshi Dong
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacological Effects of Natural Compounds
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Genomics, phytochemicals, and oxidative stress 4
- Oncology 17
- Pancreatic and Hepatic Oncology Research 8
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Yan Qi (10 shared papers)Jinyong Peng (10 shared papers)Lianhong Yin (9 shared papers)Lina Xu (9 shared papers)Hong Xiang (11 shared papers)Fangyue Guo (6 shared papers)Youwei Xu (7 shared papers)Linlin Lv (11 shared papers)
- Journals
- Frontiers in Pharmacology (7 papers)Molecules (4 papers)Biomedicine & Pharmacotherapy (3 papers)Frontiers in Oncology (3 papers)Food and Chemical Toxicology (2 papers)
- Partner nations
- China
In The Last Decade
Deshi Dong
53 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 119
- Pharmacology 209
- Biochemistry 63
- Hepatology 71
- Complementary and alternative medicine 66
- Molecular Biology 518
Countries citing papers authored by Deshi Dong
This map shows the geographic impact of Deshi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deshi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deshi Dong more than expected).
Fields of papers citing papers by Deshi Dong
This network shows the impact of papers produced by Deshi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deshi Dong. The network helps show where Deshi Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Deshi Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 124 | |
| 2 | 2013 | 100 | |
| 3 | 2013 | 89 | |
| 4 | 2014 | 67 | |
| 5 | 2013 | 55 | |
| 6 | 1979 | 51 | |
| 7 | 2022 | 42 | |
| 8 | 2023 | 42 | |
| 9 | 2014 | 42 | |
| 10 | 2020 | 41 | |
| 11 | 2015 | 36 | |
| 12 | 2014 | 34 | |
| 13 | 2020 | 30 | |
| 14 | 2022 | 25 | |
| 15 | 2023 | 22 | |
| 16 | 2022 | 22 | |
| 17 | 2021 | 20 | |
| 18 | 2008 | 19 | |
| 19 | 2023 | 18 | |
| 20 | 1980 | 17 |
About Deshi Dong
Deshi Dong is a scholar working on Molecular Biology, Oncology, Epidemiology, Pharmacology and Immunology, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Pancreatic and Hepatic Oncology Research (8 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Diet, Metabolism, and Disease (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Pharmacological Effects of Natural Compounds (4 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Pharmacology (209 citations), Biochemistry (63 citations), Hepatology (71 citations), Complementary and alternative medicine (66 citations) and Molecular Biology (518 citations). Deshi Dong has collaborated with scholars based in China. Frequent co-authors include Yan Qi, Jinyong Peng, Lianhong Yin, Lina Xu, Hong Xiang, Fangyue Guo, Youwei Xu, Linlin Lv, Xu Han and Shilei Yang. Their work appears in journals such as Frontiers in Pharmacology, Molecules, Biomedicine & Pharmacotherapy, Frontiers in Oncology and Food and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.